Literature DB >> 11945171

Cathelicidin peptides as candidates for a novel class of antimicrobials.

Margherita Zanetti1, Renato Gennaro, Barbara Skerlavaj, Linda Tomasinsig, Raffaella Circo.   

Abstract

Cathelicidin peptides are a numerous group of mammalian cationic antimicrobial peptides. Despite a common evolutionary origin of their genes, peptides display a remarkable variety of sizes, sequences and structures. Their spectra of antimicrobial activity are varied and cover a range of organisms that includes bacteria, fungi and enveloped viruses. In addition, they bind to and neutralize the effects of endotoxin. These features make this family of peptides good candidates in view of a therapeutic use. The most promising ones are currently under evaluation as leads for the development of novel anti-infectives, and synthetic variants are in an advanced stage of development for specific clinical applications. This review focuses on recent studies on the structure and in vitro and in vivo biological activities of these peptides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945171     DOI: 10.2174/1381612023395457

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  21 in total

1.  Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.

Authors:  Sathiah Thennarasu; Anmin Tan; Rajesh Penumatchu; Charles E Shelburne; Deborah L Heyl; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2010-01-20       Impact factor: 4.033

2.  Utilizing ESEEM spectroscopy to locate the position of specific regions of membrane-active peptides within model membranes.

Authors:  Raanan Carmieli; Niv Papo; Herbert Zimmermann; Alexey Potapov; Yechiel Shai; Daniella Goldfarb
Journal:  Biophys J       Date:  2005-10-28       Impact factor: 4.033

Review 3.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

4.  The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization.

Authors:  Yanjing Xiao; Alvaro I Herrera; Yugendar R Bommineni; Jose L Soulages; Om Prakash; Guolong Zhang
Journal:  J Innate Immun       Date:  2008-11-14       Impact factor: 7.349

5.  Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathway in Candida albicans.

Authors:  Maciej Lis; Teresa T Liu; Katherine S Barker; P David Rogers; Libuse A Bobek
Journal:  FEMS Yeast Res       Date:  2010-05-29       Impact factor: 2.796

6.  Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments.

Authors:  C Nagant; B Pitts; K Nazmi; M Vandenbranden; J G Bolscher; P S Stewart; J-P Dehaye
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

7.  Cathelicidin-deficient (Cnlp -/- ) mice show increased susceptibility to Pseudomonas aeruginosa keratitis.

Authors:  Ling C Huang; Rose Y Reins; Richard L Gallo; Alison M McDermott
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

8.  Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid.

Authors:  Shin Morizane; Kenshi Yamasaki; Filamer D Kabigting; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2010-01-21       Impact factor: 8.551

9.  Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.

Authors:  Anna Di Nardo; Kenshi Yamasaki; Robert A Dorschner; Yuping Lai; Richard L Gallo
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Human salivary MUC7 mucin peptides: effect of size, charge and cysteine residues on antifungal activity.

Authors:  Hongsa Situ; Guoxian Wei; Christina J Smith; Shirin Mashhoon; Libuse A Bobek
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.